Initial findings showed that when compared with a less potent P2Y12 inhibitor (P2Y12-I), potent P2Y12-Is were associated with lower risk for lethal sepsis in dialysis patients with ESKD.6 Whether this finding translates to patients with CKD who are not receiving dialysis is unclear. Here, P2RY12 is linked to Sepsis.